The Valley Desk

NCT06679582 · Interventional trial

Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Acute Myeloid Leukemia (AML)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov